Europe attacking access to affordable generic drugs | Bangkok Post: opinion

Opinion > Opinion

Europe attacking access to affordable generic drugs

Millions of people in developing countries rely on affordable quality generic medicines produced in India to stay alive. In fact, Medecins Sans Frontires (MSF) sources more than 80% of the HIV medicines it uses to treat 160,000 patients across the world from India, and a recent study found that from 2003-2008, more than 80% of donor-funded purchases of HIV medicines came from India.

Children with Aids (above) are looked after at the child care centre in Phnom Penh. Below is a poster distributed by the Vineeta Foundation. Today’s innocent children born with Aids will also be affected by the difficulties associated with accessing vital treatment.

Manufacturers in India have been able to produce cheaper versions of drugs patented elsewhere because until 2005, the country did not grant patents on medicines and multiple producers competed for the market, driving prices for the most-affordable drug combination down by more than 99% over the last decade.

This article is older than 60 days, which we reserve for our premium members only.You can subscribe to our premium member subscription, here.

About the author

Writer: Paul Cawthorne

Your comments

Reply

Sign in once and access every part of the website at your convenience!

Please log in to our Bangkokpost.com community to post your comment.
You can sign in to the community by clicking here.

If you are not part of the community yet, please sign up here. By being part of this community you will get all these privileges.